Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Phytopharm becomes vehicle for IXICO listing

This article was originally published in Scrip

Executive Summary

The struggling UK pharmaceutical company Phytopharm is to be subsumed into dementia diagnostics firm IXICO in a reverse takeover worth around £5.6m ($9m). Phytopharm's shares have been in the doldrums since it reported in February that its Cogane drug candidate had failed in a Phase II trial in early-stage Parkinson's disease (, 18 February 2013). It will now become a vehicle for the privately held UK firm IXICO to gain a public listing.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts